vs

Side-by-side financial comparison of Core Laboratories Inc. (CLB) and TOMPKINS FINANCIAL CORP (TMP). Click either name above to swap in a different company.

TOMPKINS FINANCIAL CORP is the larger business by last-quarter revenue ($194.8M vs $121.8M, roughly 1.6× Core Laboratories Inc.). TOMPKINS FINANCIAL CORP runs the higher net margin — 49.4% vs 4.2%, a 45.2% gap on every dollar of revenue. On growth, TOMPKINS FINANCIAL CORP posted the faster year-over-year revenue change (152.7% vs -1.4%). TOMPKINS FINANCIAL CORP produced more free cash flow last quarter ($31.9M vs $517.0K). Over the past eight quarters, TOMPKINS FINANCIAL CORP's revenue compounded faster (63.6% CAGR vs -3.4%).

Abbott Laboratories, commonly known as Abbott, is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois. The company produces pharmaceuticals for sale outside the United States, diagnostic products, nutritional products, and medical devices.

Tompkins Financial Corporation is a small, diversified financial services company based in Ithaca, New York. It is the parent of the Tompkins Trust Company, as well as several other banks, an insurance agency, and a wealth management division.

CLB vs TMP — Head-to-Head

Bigger by revenue
TMP
TMP
1.6× larger
TMP
$194.8M
$121.8M
CLB
Growing faster (revenue YoY)
TMP
TMP
+154.1% gap
TMP
152.7%
-1.4%
CLB
Higher net margin
TMP
TMP
45.2% more per $
TMP
49.4%
4.2%
CLB
More free cash flow
TMP
TMP
$31.4M more FCF
TMP
$31.9M
$517.0K
CLB
Faster 2-yr revenue CAGR
TMP
TMP
Annualised
TMP
63.6%
-3.4%
CLB

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
CLB
CLB
TMP
TMP
Revenue
$121.8M
$194.8M
Net Profit
$5.1M
$96.2M
Gross Margin
Operating Margin
1.5%
71.7%
Net Margin
4.2%
49.4%
Revenue YoY
-1.4%
152.7%
Net Profit YoY
388.9%
EPS (diluted)
$0.11
$6.72

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLB
CLB
TMP
TMP
Q1 26
$121.8M
Q4 25
$138.3M
$194.8M
Q3 25
$134.5M
$87.4M
Q2 25
$130.2M
$82.6M
Q1 25
$123.6M
$81.7M
Q4 24
$129.2M
$77.1M
Q3 24
$134.4M
$76.6M
Q2 24
$130.6M
$72.7M
Net Profit
CLB
CLB
TMP
TMP
Q1 26
$5.1M
Q4 25
$4.9M
$96.2M
Q3 25
$14.2M
$23.7M
Q2 25
$10.6M
$21.5M
Q1 25
$-154.0K
$19.7M
Q4 24
$7.4M
$19.7M
Q3 24
$11.7M
$18.6M
Q2 24
$9.0M
$15.7M
Gross Margin
CLB
CLB
TMP
TMP
Q1 26
Q4 25
20.8%
Q3 25
22.0%
Q2 25
20.3%
Q1 25
19.5%
Q4 24
17.8%
Q3 24
20.5%
Q2 24
21.2%
Operating Margin
CLB
CLB
TMP
TMP
Q1 26
1.5%
Q4 25
11.5%
71.7%
Q3 25
15.6%
35.6%
Q2 25
11.7%
34.2%
Q1 25
3.6%
31.6%
Q4 24
11.0%
33.4%
Q3 24
14.7%
32.0%
Q2 24
12.3%
28.3%
Net Margin
CLB
CLB
TMP
TMP
Q1 26
4.2%
Q4 25
3.6%
49.4%
Q3 25
10.6%
27.1%
Q2 25
8.2%
26.0%
Q1 25
-0.1%
24.1%
Q4 24
5.7%
25.5%
Q3 24
8.7%
24.3%
Q2 24
6.9%
21.6%
EPS (diluted)
CLB
CLB
TMP
TMP
Q1 26
$0.11
Q4 25
$0.11
$6.72
Q3 25
$0.30
$1.65
Q2 25
$0.22
$1.50
Q1 25
$0.00
$1.37
Q4 24
$0.15
$1.39
Q3 24
$0.25
$1.30
Q2 24
$0.19
$1.10

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLB
CLB
TMP
TMP
Cash + ST InvestmentsLiquidity on hand
$22.8M
$132.8M
Total DebtLower is stronger
Stockholders' EquityBook value
$275.1M
$938.4M
Total Assets
$587.7M
$8.7B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLB
CLB
TMP
TMP
Q1 26
$22.8M
Q4 25
$22.7M
$132.8M
Q3 25
$25.6M
$193.5M
Q2 25
$31.2M
$212.6M
Q1 25
$22.1M
$193.1M
Q4 24
$19.2M
$134.4M
Q3 24
$21.5M
$132.3M
Q2 24
$17.7M
$70.9M
Total Debt
CLB
CLB
TMP
TMP
Q1 26
Q4 25
$110.3M
Q3 25
$114.1M
Q2 25
$124.6M
Q1 25
$124.4M
Q4 24
$126.1M
Q3 24
$139.9M
Q2 24
$147.6M
Stockholders' Equity
CLB
CLB
TMP
TMP
Q1 26
$275.1M
Q4 25
$266.0M
$938.4M
Q3 25
$271.3M
$788.8M
Q2 25
$261.3M
$761.8M
Q1 25
$253.4M
$741.4M
Q4 24
$246.6M
$713.4M
Q3 24
$250.7M
$719.9M
Q2 24
$240.3M
$674.6M
Total Assets
CLB
CLB
TMP
TMP
Q1 26
$587.7M
Q4 25
$584.0M
$8.7B
Q3 25
$591.4M
$8.5B
Q2 25
$602.1M
$8.4B
Q1 25
$591.5M
$8.2B
Q4 24
$585.1M
$8.1B
Q3 24
$600.5M
$8.0B
Q2 24
$597.8M
$7.9B
Debt / Equity
CLB
CLB
TMP
TMP
Q1 26
Q4 25
0.41×
Q3 25
0.42×
Q2 25
0.48×
Q1 25
0.49×
Q4 24
0.51×
Q3 24
0.56×
Q2 24
0.61×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLB
CLB
TMP
TMP
Operating Cash FlowLast quarter
$4.0M
$38.9M
Free Cash FlowOCF − Capex
$517.0K
$31.9M
FCF MarginFCF / Revenue
0.4%
16.4%
Capex IntensityCapex / Revenue
3.6%
Cash ConversionOCF / Net Profit
0.77×
0.40×
TTM Free Cash FlowTrailing 4 quarters
$22.5M
$105.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLB
CLB
TMP
TMP
Q1 26
$4.0M
Q4 25
$7.9M
$38.9M
Q3 25
$8.5M
$34.9M
Q2 25
$13.9M
$18.9M
Q1 25
$6.7M
$22.2M
Q4 24
$20.6M
$95.0M
Q3 24
$13.1M
$21.2M
Q2 24
$17.1M
$27.3M
Free Cash Flow
CLB
CLB
TMP
TMP
Q1 26
$517.0K
Q4 25
$5.0M
$31.9M
Q3 25
$6.5M
$33.9M
Q2 25
$10.4M
$18.3M
Q1 25
$3.9M
$20.9M
Q4 24
$17.4M
$88.8M
Q3 24
$10.4M
$18.9M
Q2 24
$14.3M
$26.3M
FCF Margin
CLB
CLB
TMP
TMP
Q1 26
0.4%
Q4 25
3.6%
16.4%
Q3 25
4.8%
38.8%
Q2 25
8.0%
22.1%
Q1 25
3.1%
25.5%
Q4 24
13.4%
115.1%
Q3 24
7.7%
24.7%
Q2 24
10.9%
36.2%
Capex Intensity
CLB
CLB
TMP
TMP
Q1 26
Q4 25
2.1%
3.6%
Q3 25
1.5%
1.1%
Q2 25
2.7%
0.8%
Q1 25
2.3%
1.7%
Q4 24
2.5%
8.1%
Q3 24
2.0%
2.9%
Q2 24
2.2%
1.3%
Cash Conversion
CLB
CLB
TMP
TMP
Q1 26
0.77×
Q4 25
1.61×
0.40×
Q3 25
0.60×
1.47×
Q2 25
1.31×
0.88×
Q1 25
1.13×
Q4 24
2.78×
4.82×
Q3 24
1.12×
1.14×
Q2 24
1.90×
1.74×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons